根据第八届药典委员会全体会议通过的《中国药典》2 0 0 5年版的整体设计方案 ,《中国生物制品规程》并入药典 ,作为《中国药典》2 0 0 5年版 (三部 ) ,这一重大改革进一步推进了我国药品标准的协调和统一。按照《中国药典》2 0 0 5年版的整体设计方案所确定的指导思想 ,遵循“ According to the overall design proposal of the 2005 edition of “Chinese Pharmacopoeia” adopted by the Eighth Plenary Session of the Pharmacopoeia Commission, “China’s Biological Products Regulations” are incorporated into Pharmacopoeia as part of the Chinese Pharmacopoeia 2005 edition A major reform further promoted the harmonization and unification of China’s drug standards. In accordance with the guiding ideology set forth in the overall design plan of the 2005 edition of the Chinese Pharmacopoeia,